Patient-related risk factors for urinary retention following ambulatory general surgery: Asystematic review and meta-analysis by Mason, SE et al.
Accepted Manuscript
Patient-Related Risk Factors for Urinary Retention Following Ambulatory General
Surgery; a Systematic Review and Meta-Analysis
Sam E. Mason, Alasdair J. Scott, Erik Mayer, Sanjay Purkayastha
PII: S0002-9610(15)00373-6
DOI: 10.1016/j.amjsurg.2015.04.021
Reference: AJS 11589
To appear in: The American Journal of Surgery
Received Date: 6 February 2015
Revised Date: 22 April 2015
Accepted Date: 25 April 2015
Please cite this article as: Mason SE, Scott AJ, Mayer E, Purkayastha S, Patient-Related Risk Factors
for Urinary Retention Following Ambulatory General Surgery; a Systematic Review and Meta-Analysis,
The American Journal of Surgery (2015), doi: 10.1016/j.amjsurg.2015.04.021.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to
our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and all
legal disclaimers that apply to the journal pertain.
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
1 
 
Patient-Related Risk Factors for Urinary Retention Following Ambulatory 
General Surgery; a Systematic Review and Meta-Analysis 
 
Sam E Masona, Alasdair J Scotta, Erik Mayera, Sanjay Purkayasthaa 
aAcademic Surgical Unit, Imperial College London, UK 
 
Corresponding Author: 
Dr Sam Mason BSc (Hons), MBBS, MRCS 
Address: Division of Surgery, Imperial College London, 10th Floor Queen Elizabeth the Queen Mother 
Building, St Mary's Hospital Campus, South Wharf Road, London, W2 1NY. 
Email: sam.mason06@imperial.ac.uk 
Telephone: +442033126666 
 
Co-Authors: 
Dr Alasdair Scott BSc (Hons), MBBS, PhD. Email: alasdair.scott03@imperial.ac.uk 
Dr Erik Mayer BSc (Hons), MBBS, PhD, FRCS. Email: e.mayer@imperial.ac.uk 
Dr Sanjay Purkayastha BSc, MBBS, MD, FRCS. Email: s.purkayastha@imperial.ac.uk 
 
 
 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
Abstract 
Background 
Post-Operative Urinary Retention (POUR) is a source of avoidable patient harm. The aim of this review is to 
identify and quantify the role of patient-related risk factors in the development of POUR following 
ambulatory general surgery. 
 
Methods 
Studies published until December 2014 were identified by searching MEDLINE, EMBASE and PsycINFO 
databases. Risk factors assessed in three or more studies were meta-analysed. 
 
Results 
Twenty-one studies were suitable for inclusion consisting of 7802 patients. The incidence of POUR was 
14%. Increased age and the presence of lower urinary tract symptoms significantly increased risk with ORs 
of 2.11 (95% CI 1.15-3.86) and 2.83 (1.57-5.08) respectively. Male sex was not associated with developing 
POUR - OR 0.96 (0.62-1.50).  Pre-operative α-blocker use significantly decreased the incidence of POUR 
with an OR 0.37 (0.15-0.91).  
 
Conclusions 
Increased age and the presence of lower urinary tract symptoms increases the risk of POUR, whilst α-
blocker use confers protection. Male sex was not associated with POUR. These findings assist in pre-
operative identification of patients at high risk of POUR. 
Keywords: Systematic Review, Urinary Retention, Surgical Treatment, Risk Factors 
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Background 
Post-Operative Urinary Retention (POUR) refers to the inability to initiate adequate micturition despite 
bladder distension in the early post-operative period1. It has been described as a complication of day-case 
general surgery for over 50 years but remains a common problem in modern day surgical practice, with 
reported incidences up to 49%2.  
POUR is an obstacle in the provision of high quality surgical care. It results in an increased morbidity for 
patients including the risks associated with bladder catheterisation (urinary tract infection) and the 
psychological consequences of an unexpected surgical complication. POUR is responsible for 20-25% of 
unexpected inpatient admissions following day-case general surgery3,4, which has a direct cost implication to 
the institution but may also threaten the ability to accept elective operative admissions. Even when POUR is 
managed on an out-patient basis, the institution will need to provide a pathway to manage this, typically 
requiring urologist and specialist nurse clinics. The transition away from in-patient surgery with routine 
bladder catheterisation and towards day-case procedures means the impact of POUR on surgical care is only 
going to increase. Furthermore, ever-increasing financial pressures have stimulated a drive towards increased 
efficiency in the provision of healthcare services. This is threatened by conditions such as POUR, where 
unexpected and potentially unnecessary costs may divert limited resources from providing high quality care.  
Optimisation of the day-case surgical pathway can be achieved with pre-operative identification of patients 
at high risk of POUR and initiation of prophylactic interventions. In order to achieve risk prediction on a 
patient level it is necessary to understand the role and interplay of the factors which increase the risk of, or 
provide protection against, POUR. Within ambulatory general surgery, several risk factors have been 
established relating to operative factors (including equipment and technique5-12) and anaesthetic factors 
(including intravenous fluid use and route of anaesthesia13-23). However there is a paucity of work on the 
influence of patient-related factors. Patient-related factors are those unrelated to the surgery or anaesthesia 
and are pre-operatively identifiable, likely to include demographic data, comorbid status and 
pharmacological history.  
The aim of this systematic review with meta-analysis is to appraise the literature to identify and quantify the 
influence of patient-related risk factors on the development of POUR after day-case general surgery. 
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Methods 
A systematic review with meta-analysis was carried out in accordance with the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement24. 
 
Literature Search Strategy 
General surgical procedures that could be performed in an ambulatory setting were identified after discussion 
and consensus between the authors. A search strategy was then designed to identify studies published in peer 
reviewed journals which report the risk factors for developing POUR after such procedures, using terms 
including ‘(urine OR urinary) AND retention’, ‘(void* OR micturi*) AND (dysfunction OR difficult*)’, 
‘post-operative’, ‘general surg*’ and ‘anorectal’. Using Ovid SP©, the following electronic databases were 
searched until the fourth week of December 2014 for English language articles: MEDLINE (1950-present), 
Embase (1947-present) and PsycINFO (1806-present). In addition the bibliographies of review articles 
returned in the search were examined to identify any additional studies of interest.  
 
Criteria for Study Inclusion 
Two authors (S.M. and A.S.) independently applied the inclusion criteria to the search results. This was 
achieved by initial title and abstract screening followed by retrieval of manuscripts for all studies that could 
not be excluded at the screening stage or where an abstract was not available. For inclusion, studies must use 
an experimental or observational design to compare the incidence of POUR across at least two cohorts 
defined by the presence or absence of a specified patient-related risk factor. Patient-related risk factors are 
defined as pre-operatively identifiable and unrelated to the surgery or anaesthesia, such as demographic data, 
comorbid status and pharmacological history. All patients must have been age sixteen or over at the time of 
surgery. Studies were excluded if they did not present primary data (review articles, commentaries) or were 
abstracts published in conference proceedings. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
Surgical Intervention 
For inclusion in this review, the surgical intervention must be usually performed by a general surgeon and be 
possible to be performed on a day-case basis. The following procedures were deemed suitable: abdominal 
wall hernia repair (open or laparoscopic), anorectal procedures for anal fissures, fistulas, haemorrhoids and 
abscesses; laparoscopic cholecystectomy, pilonidal sinus excision, mucosal resection for rectal prolapse, 
Nissen’s fundoplication and Heller’s myotomy. In the case of two or more simultaneous surgical procedures, 
it was necessary that all fulfil the criteria of a suitable surgical intervention as stated here. Surgical 
procedures for the purpose of weight reduction or for malignant conditions were excluded. As routine intra-
operative bladder catheterisation was used variably between institutions, and given its nature as a potential 
confounder and intervention to decrease the incidence of POUR, studies were excluded if there was a 
statistically significant difference in the rate of intra-operative catheterisation between the cohorts of interest.  
 
Definition of Post-Operative Urinary Retention 
POUR was defined as post-operative patient catheterisation for difficulty in voiding or if the authors used the 
term ‘urinary retention’. In order for the urinary retention to be considered ‘post-operative’, it needed to be in 
the early post-operative period, typically less than 24 hours.  
 
Data Extraction 
One author (S.M.) extracted the following data from each included study into a Microsoft Excel© 2010 
(Microsoft Corporation, Redmond, Washington, USA) database: author, year, study design, number of 
patients, surgical procedure undertaken, risk factor examined and the incidence of POUR in each cohort. 
Study design was described as prospective or retrospective, with the former defined as identification of the 
potential risk factor pre-operatively with future detection of POUR. Retrospective studies in this setting were 
case-control by design, post-operatively identifying patients in POUR and then collecting data on potential 
pre-operative risk factors. Within the prospective group, studies were described as randomised controlled 
trials (RCT) only if the patient-related risk factor of interest was allocated by randomisation. 
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Statistical Analysis 
All analyses were performed in R (Foundation for Statistic Computing, Vienna, Austria) using the metafor 
package25. It was required that studies presented discrete data. The incidences of POUR in the risk factor and 
control cohorts were used to calculate odds ratios. Where three or more independent studies had evaluated a 
risk factor, the odds ratios were pooled using a random-effects model (restricted maximum likelihood 
approach) to generate a summary odds ratio and 95% confidence interval. A random effects model was used 
after significant functional differences were found on examination of study manuscripts. P values were 
calculated for comparison against the null hypothesis of no effect (OR = 1). The I2 statistic and Cochran’s Q 
test were used to quantify heterogeneity between studies. To assess the influence of individual studies on the 
summary effect size, a sensitivity analysis was performed whereby the model was repeatedly fitted with 
sequential omission of each study. Where appropriate, funnel plots were generated and tested for asymmetry 
by regression to diagnose publication bias26. A P value less than or equal to 0.05 was considered significant. 
The quality of the included studies was assessed using a Jadad score27 or the Newcastle-Ottawa scale 
(NOS)28, which have been validated for randomised and non-randomised studies respectively. The Jadad 
score assesses randomisation, blinding and completeness of follow-up with a maximum score of five, where 
below three represents low methodological quality. The NOS can be applied to prospective or case-control 
studies where a maximum of nine stars can be awarded based on criteria such as follow-up, cohort 
comparability and selection of controls; a score of below six considered low quality. 
Where appropriate, subgroup analyses were performed based on study design and methodological quality. 
 
Results 
The search identified 3759 potential studies, 3714 from electronic bibliographies and 45 from review articles 
by hand searching. The majority were excluded at abstract screening, most commonly for inappropriate 
procedure or study design, with 570 manuscripts reviewed in full (Figure 1).  
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Twenty-one studies were deemed suitable for inclusion (Table 1). In total 7802 patients were included with 
an overall POUR incidence of 14%. All procedures involved either groin hernia repairs or anorectal 
procedures including abscess drainage, lateral sphincterotomy and haemorrhoidectomy. All analyses were 
undertaken on study groups receiving exclusively hernia repairs or anorectal procedures, with no mixture of 
cases. 
Ten patient-related factors were identified in the included studies: age, gender, pre-operative α-adrenoceptor 
blocker use, previous lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), prostate 
cancer, American Society of Anesthesiologists (ASA) score, previous urinary retention, human 
immunodeficiency virus (HIV) infection and diabetes mellitus. Of these, age, gender, LUTS and pre-
operative α-blocker use were investigated in three or more manuscripts and were therefore suitable for meta-
analysis. 
 
Methodological Quality 
Of the twenty-one included studies, four were RCTs, seven were prospective cohort and the remaining ten 
were case-control. Jadad and NOS assessment showed median scores of 2 (range 1-4) and 6 (range 5-8) 
respectively, with five studies considered of low methodological quality. The only patient-related risk factor 
in the meta-analysis to be assessed using only prospective studies was the role of α-blockers, where the 
criteria for patient selection, method of allocation and blinding were either inadequate or not described in the 
majority of studies. Three of the five studies29,32,33 assessing α-blockers were considered of poor 
methodological quality with high risk of systematic bias.  
The role of gender, age and LUTS were all evaluated by pooling prospective and retrospective studies at a 
ratio of approximately 1:2. LUTS, the only subjective factor in the meta-analysis, was defined by only one 
study40 and retrospectively applied in four of the six. Despite none of these studies being considered of low 
methodological quality on NOS assessment, the authors considered these papers at high risk of selection and 
reporting biases.  
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When assessing the role of age, authors arbitrarily defined an age threshold to divide their patients into high 
and low age groups, with 50, 55 and 70 years most commonly used. In two of the four retrospective studies, 
it appears that the age cut-off was defined post-hoc, likely after initial analysis of the data.  One study was 
considered of low methodological quality, retrospective by design and unable to account for a lack of 
baseline similarity between the cohorts.  
No studies on the role of gender were considered of low methodological quality on NOS assessment. 
Although gender was rarely a pre-defined factor of interest in the risk of developing POUR, this was 
considered to have a low risk of bias on the results.  
 
Description of Results 
Gender 
Ten studies36-40,42,45-48  (5624 patients) assessed the influence of gender on the risk of developing POUR. The 
only two studies that demonstrated a significant relationship both identified male gender as protective40,45, 
however once the studies had been pooled, male sex was not found to significantly influence the risk of 
developing POUR with a summary OR of 0.96 (figure 2, 95% CI 0.62-1.50, p=0.87). Including only 
prospective studies did not affect the lack of association between sex and POUR (data not shown). 
 
Age 
Eight studies34-41 (5407 patients), one of which presented two distinct cohorts (based on the surgical 
procedure)36, assessed the influence of age. Overall, older patients had a significantly increased risk of 
POUR compared to younger patients with a summary OR of 2.11 (figure 3, 95% CI 1.15-3.86, p=0.02). Sub-
group analyses were conducted with studies using age cut-offs of ≥50, ≥55 and ≥60 years (Figure 4). This 
demonstrates a marked increase in risk once age cut-offs of ≥60 years were used, with a summary OR of 
7.09 (95% CI 2.79-18.03). Exclusion of low quality or retrospective studies continued to demonstrate a 
significant association between increased age and POUR (data not shown). 
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Lower Urinary Tract Symptoms 
When referring to symptoms of the lower urinary tract, authors either used the term ‘LUTS’ or ‘BPH’, with 
all but one giving no definition of these terms. For the purpose of the analysis it was considered that these 
two groups were indistinct and they were pooled under the term 'LUTS'. The six studies8,36,37,40-42 (3821 
patients) demonstrated that a history of LUTS significantly increased the risk of POUR with a summary OR 
of 2.83 (figure 5, 95% CI 1.57-5.08, p=<0.001).  
 
Pre-Operative α-Blocker Use 
Five studies29-33 (455 patients) assessed the influence of pre-operative α-blocker use on the incidence of 
POUR, three with prazosin and one each with phenoxybenzamine and tamsulosin. Four were RCTs and all 
were within the context of an interventional trial. The time of the first α-blocker dose being administered 
varied between 6 and 24 hours pre-operatively across the studies. Three studies29,30,32 were conducted 
exclusively in male patients while the gender of the patients in the remaining two31,33 was unclear. Overall, 
α-blocker use was found to significantly reduce the risk of POUR with a summary OR of 0.37 (figure 6, 
95% CI 0.15-0.91, p=0.03). If any of the studies of low methodological quality are removed from the 
analysis, the significant protection from α-blockers is no longer demonstrated. Eggers regression test for 
funnel plot asymmetry was negative (p=0.85). 
 
Additional Patient-Related Risk Factors 
Five studies8,40,42-4 described the further patient related-risk factors for which there was insufficient data for 
meta-analysis. ASA grades 3-4 (compared to 1-2) was a significant risk factor for POUR shown in one study 
with an OR of 6.75 (1.30-35.17). Previous urinary retention or HIV infection were not shown to significantly 
increase the risk of POUR. Diabetes mellitus and the presence of prostate cancer were each assessed by two 
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studies and in both cases one study found a significantly increased risk with the other demonstrating 
equivalence. 
 
Heterogeneity and Sensitivity Analysis 
As expected from the inherent variability in study methodology, there was significant inter-study 
heterogeneity evidenced by Cochrane’s Q tests and I2 values for the analyses of age, sex and LUTS. Tests for 
heterogeneity were not significant for α-blocker analysis (Q=6.45, p=0.17, I2=23%). However, visual 
inspection of the relevant forest plot (Figure 2) and the size of the standard error for the pooled estimate 
(0.468) indicated a large degree of variation within each study. In combination with the low number of 
studies available, this is likely to render any tests of heterogeneity underpowered. These heterogeneity data 
support the application of a random effects model in carrying out the meta-analyses. Refitting the models 
with sequential removal of each study had no significant impact on the summary effect sizes for age, gender 
or LUTS (data not shown). The α-blocker analysis was not so robust as removal of any one of four 
studies29,31-33 resulted in the 95% confidence intervals for the new summary effect sizes overlaping 1, 
indicating no effect (data not shown). 
 
Discussion 
This meta-analysis aimed to identify patient-related risk factors for the development of POUR following 
ambulatory general surgery and demonstrated that increased age and pre-operative LUTS significantly 
increased the risk of POUR, whilst pre-operative α-blocking medications provided significant protection. 
Of the five studies which evaluated interventional prophylactic use of α-blockers, four demonstrated no 
significant difference in the incidence of POUR; however the pooled estimate indicated that these agents are 
protective in this setting. There was no significant heterogeneity identified between these studies based on 
the Cochran Q score, however all demonstrated poor accuracy with large 95% CIs; reflected in the CI of the 
pooled estimate ranging from 0.15 to 0.91. It was determined upon manuscript examination that these studies 
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are in fact heterogeneous when considering factors including surgical procedure and anaesthetic type. Given 
the small number of studies and the large intra-study variance, the statistical tests of heterogeneity are almost 
certainly underpowered. The intra-study variance also means that although the data suggests α-blockade is 
protective, no clinically meaningful estimate as to the extent of that protection can be given. It is also 
important to consider the timing that the α-blockers were administered pre-operatively, with all studies 
giving them less than 24 hours pre-operatively. Although the product literature of a common α-blocker 
(tamsulosin) describes a peak plasma concentration at 4-7 hours, it is possible that more than 24 hours is 
required for these agents to exert a maximum clinical effect. As a result, many of the studies included in this 
review may show a false lack of association and there is a need for an adequately powered randomised 
controlled trial with a greater period of pre-operative α-blocker administration. Additionally, given that the 
majority of studies were conducted with a male population, the role of these agents in a female population 
needs to be assessed. This will determine with greater precision the benefit surgeons and patients can expect 
from prophylactic α-blocker use.  
Eight studies in this review demonstrated increased age as a risk factor for POUR, a finding which has been 
shown following many types of surgery in the ambulatory and inpatient settings1,49-53. Sub-group analysis 
demonstrated a marked increase in the risk of POUR once an age cut-off of ≥60 years was used. The discrete 
nature of the data only allowed three sub-group analyses, but this data suggests that patients over the age of 
60 should be considered at increased risk.   
Male gender, although understood to be a risk factor for non-operative urinary retention, has been shown 
across the nine studies here not to be a risk factor for POUR. This is consistent with the literature across 
other surgical specialities including orthopaedics, thoracic, vascular and otolaryngology; where neither 
gender has been consistently identified to confer risk49-51,54.  
Pre-operative LUTS have been demonstrated in this analysis to increase the risk of POUR in what was a 
largely mixed gender population. This finding is consistent with patients undergoing orthopaedic surgery, 
where LUTS increases the risk of POUR independent of gender55. It is apparent that there are no established 
definitions being applied for the terms LUTS and BPH, which appear to be used interchangeably to describe 
subjective symptoms including frequency, urgency, straining and weak stream. The fact that only one study 
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defined LUTS or BPH limits the external validity of the finding that this cohort of patients are at risk factor 
of POUR. It is recommended that future studies state the definition of terms such a 'lower urinary tract 
symptoms'. 
The quality of the data in the literature and that several potentially confounding factors are at play means it is 
not possible to draw conclusions either about the mechanism by which the micturition pathway is disrupted 
in POUR or the interaction between patient-related risk factors.  
The methodological quality of the studies in this area provide the greatest challenge in understanding POUR 
and also provides a potential source of bias in this analysis. Given the nature of patient-related risk factors 
and in particular that they are often non-modifiable, it is rarely possible to perform randomised controlled 
trials. However ten of the twenty-one studies were retrospective case-control design. Case-controlled studies 
are more likely than their prospective counterparts of making errors due to recall, observer and reporting 
biases. Furthermore they are less capable in identifying confounding factors for which sufficient data can be 
collected to identify risk factors in multi-variant analysis. Subgroup analyses were performed based on study 
design and methodological quality, which determined there was no evidence of such biases influencing the 
results. This may have been due to the inability of the NOS to adequately distinguish between high and low 
quality surgical trials. It was found that all studies were awarded quality stars for 'ascertainment of exposure' 
(the surgical procedure) and adequacy of follow-up (the immediate post-operative period). However this 
acted to dilute the influence of likely a more differentiating factor (comparability of cohorts), for which only 
one star is available. This highlights the need for quality scoring systems more suited to surgical trials. 
A further challenge in pooling data for this meta-analysis was that studies often used varying cut-offs or 
definitions for factors of interest, sometimes giving no definition at all. This was encountered when 
considering an age cut-off to define a high risk patient, a time to administer prophylactic α-blockers or a 
definition of the term LUTS.  
It is apparent from this review how poorly the group of patients at risk of POUR is understood. In the 
consideration of patient risk management and cost-efficient service delivery, this review has several 
implications for practice both in the community and within the surgical setting. POUR is common and a 
significant cause of admission to hospital following ambulatory general surgery. When overnight admission 
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occurs the 11-70% cost saving expected from an ambulatory pathway will be obviated56. When patients are 
managed as an outpatient with an indwelling urinary catheter they are at a 5% per day risk of a urinary tract 
infection with 2-4% of those developing bacteraemia57,58. The impact of this on both patients and healthcare 
institutions is apparent when considering that 34.7 million ambulatory surgery visits were made in the USA 
in 2006 alone, an ever increasing figure59. It is likely that both increased age and symptomatic voiding 
dysfunction are risk factors for POUR. Therefore in order to provide high quality care it is necessary to 
identify these patients at the earliest stage, often in the primary sector upon referral for surgical assessment. 
POUR is potentially predictable and preventable. This provides an opportunity to intervene pre-operatively 
and manage the patient expectedly. Effective prophylactic interventions already exist and include avoiding 
high risk surgical and anaesthetic techniques (such as spinal anaesthesia), or measures as simple as limiting 
post-operative oral fluid intake. The latter has been shown in an RCT to reduce the incidence of POUR from 
15 to 4%23. Optimising the ambulatory surgery pathway to identify high risk patients as early as possible to 
initiate interventions will be the most effective way of decreasing the financial and morbidity burden of 
POUR. Furthermore identifying high risk patients pre-operatively will maximize the cost/benefit/risk profile 
of any interventions made.  This most likely requires development of a validated risk score, which 
incorporates patient, surgical and anaesthetic-related factors to define risk on an individual level.   
 
Conclusion 
This study has demonstrated that increased age and the presence of pre-operative LUTS are risk factors for 
developing post-operative urinary retention following ambulatory general surgery. Prophylactic use of α-
adrenoceptor antagonists appears to decrease the incidence of POUR however there is a need for an 
adequately powered randomised controlled trial in this setting. The ambulatory surgery pathway needs to be 
optimised to pre-operatively identify high-risk patients at whom prophylactic interventions can be targeted. 
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Figure Captions 
Figure 1 – PRISMA flowchart denoting the process to include eligible studies.  
Abbreviation: RCT- randomized controlled trial.  
 
Figure 2 - Forest plot depicting the effect of gender. 
Figure 3 - Forest plot depicting the effect of age. 
Figure 4 - Forest plot of age sub-group analysis. 
Figure 5 - Forest plot depicting the effect of lower urinary tract symptoms. 
Figure 6 - Forest plot depicting the effect of α-blocker usage. 
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Table 1 
 
 
 
Author Year Study Design Operation n Risk Factor Quality 
Scorea 
Odds Ratio  
(95% CI) 
Mohammadi-
Fallah29 
2012 RCT IH 80 α-blocker 2 0.15 (0.02-1.27) 
Woo30 1995 Prospective IH 70 α-blocker 7 5.00 (0.23-108) 
Cataldo31 1991 RCT Anorectal 49 α-blocker 4 0.67 (0.22-2.07) 
Gonullu32 1999 RCT IH 156 α-blocker 2 0.23 (0.06-0.87) 
Goldman33 1988 RCT IH 102 α-blocker 1 0.06 (0.00-0.14) 
Beltran34 2006 Prospective IH 688 Age >70 7 12.43 (5.96-26.0) 
Amato35 2012 Case-Control IH 218 Age >70 5 3.34 (0.37-30.4) 
Zaheer36 1998 Case-Control Hemorr. 382 Age >55 6 1.25 (0.82-1.91) 
   Anorectal 645 Age >47  2.30 (1.07-4.93) 
   Hemorr, Anorectal 1027 LUTS  1.85 (1.04-3.30) 
   Hemorr, Anorectal 1027 Male  1.23 (0.87-1.75) 
Eftaiha37 1980 Prospective Anorectal 263 Age >55 8 1.27 (0.68-2.37) 
   Anorectal 263 LUTS  4.01 (2.11-7.62) 
   Anorectal 263 Male  1.49 (0.83-2.67) 
Lin38 2010 Case-Control Haemorr. 467 Age >55 7 0.77 (0.45-1.33) 
   Haemorr. 467 Male  1.22 (0.82-1.82) 
Prasad39 1978 Prospective Anorectal 620 Age >50 7 2.52 (0.30-21.5 
   Anorectal 620 Male  0.90 (0.20-4.06) 
Toyonaga40 2006 Case-Control Anorectal 2011 Age >50 6 1.56 (1.23-1.98) 
   Anorectal 2011 LUTS  2.19 (1.55-3.11) 
   Anorectal 2011 Male  0.33 (0.26-0.41) 
   Anorectal 2011 Diabetes  2.09 (1.15-3.78) 
Kozol41 1992 Prospective IH 113 Age >60 7 4.00 (1.15-13.9) 
   IH 113 LUTS  2.22 (0.70-7.02) 
Koch8 2006 Case-Control IH 68 BPH 6 1.17 (0.39-3.51) 
   IH 68 Prostate Cancer  1.00 (0.19 to 5.34) 
   IH 68 Previous Urinary 
Retention 
 0.56 (0.12-2.56) 
Sivasankaran42 2014 Case-Control IH 339 BPH 6 11.5 (4.75-27.6) 
   IH 339 Prostate Cancer  3.97 (1.19-13.23) 
   IH 350 Male  2.19 (0.13-38.02) 
   IH 350 Diabetes  0.58 (0.21-1.56) 
Sanjay43 2006 Case-Control IH 577 ASA 3 and 4 5 6.75 (1.30-35.17) 
Hewitt44 1996 Case-Control Hemorr. 57 HIV infection 8 0.41 (0.09-1.78) 
Iramaneerat45 2013 Case-Control Anorectal 245 Male 6 0.50 (0.26-0.95) 
Kiyak46 2009 Prospective Spincterotomy 129 Male 7 2.14 (0.86-5.32) 
Lau47 2002 Case-Control IH 300 Male  6 1.04 (0.06-18.60) 
Zack48 1962 Prospective Anorectal 212 Male 6 1.20 (0.69-2.11) 
Abbreviations: CI- confidence interval; RCT- randomized controlled trial; IH- inguinal herniorrhaphy; Hemorr.- hemorrhoidectomy.   
aJadad and Newcastle-Ottawa scores for randomized and non-randomized trials respectively 
 
Table 1 – design, clinical characteristics, risk factors and quality assessment of the twenty-one  included studies. 
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